Evidence map›Paper›PMID 30678237›Full record

ArticleMolecules (Basel, Switzerland)2019

Enhanced NADH Metabolism Involves Colistin-Induced Killing of Bacillus subtilis and Paenibacillus polymyxa.

Zhiliang Yu, Yuyi Zhu, Jianv Fu, Juanping Qiu, Jianhua Yin

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Appraisal of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Colistin Resistance in Bacteria: Current Updates on Mechanism of Action and Combating Strategies.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. TheFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhiliang YuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. zlyu@zjut.edu.cn.ORCID 0000-0003-4849-7055
Yuyi ZhuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. 2111405102@zjut.edu.cn.
Jianv FuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. 2111605001@zjut.edu.cn.
Juanping QiuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. qiujping@zjut.edu.cn.
Jianhua YinCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China. jianhuay@zjut.edu.cn.ORCID 0000-0003-1311-7606

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The commonly believed mechanism of colistin against Gram-negative bacteria is to cause cell membrane lysis, whereas the mechanism of colistin against Gram-positive bacteria is extremely fragmented. In this study, we found that colistin treatment on

Indexed as

Anti-Bacterial AgentsBacillus subtilisCitric Acid CycleColistinElectron TransportNADOxidative StressPaenibacillus polymyxaAnti-Bacterial AgentsColistinNADcolistinGram-positive bacteriaoxidative stressrespiratory chainTCA cycle

Identifiers

PMID30678237
PMCPMC6384706

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.